Stefanini G F, Biselli M, Grazi G L, Iovine E, Moscatello M R, Marsigli L, Foschi F G, Caputo F, Mazziotti A, Bernardi M, Gasbarrini G, Cavallari A
Divisione di Medicina Interna, Ospedale di Faenza (Ra).
Hepatogastroenterology. 1997 Sep-Oct;44(17):1356-9.
BACKGROUND/AIMS: Liver transplantation for alcoholic end-stage liver disease remains controversial at many transplant centers. The aim of the present study was to evaluate the outcome of patients with alcoholic liver disease who underwent liver transplantation at Centro Trapianti, Policlinico S. Orsola, Bologna.
We describe the outcomes of 18 alcoholic patients with end-stage liver disease who received orthotopic liver transplants at our center from April, 1986 to February, 1996. The data obtained was compared with that of 114 patients with virus-related cirrhosis selected as transplant controls. An absolute period of abstinence from alcohol consumption for at least six months was required.
Regarding the actuarial survival rate and non-fatal post-transplant complications, no significant differences were noted in comparing the non-alcoholic with the alcoholic recipients, except for a higher incidence of Cytomegalovirus infection in the alcoholic group followed-up for more than four months. The alcoholic relapse rate was 27.2%, but only one patient returned to harmful drinking. Seventy-three percent of subjects who were followed-up for at least six months were occupied in gainful employment. Alcoholic relapse did not affect employment status.
This data demonstrates that liver transplantation for selected patients with end-stage alcohol-related cirrhosis achieves good results in survival, complications and employment status, and it appears difficult to defend an inflexible claim to have demonstrated an absolute long-term abstinence before transplantation when a severe deterioration of liver function is present.
背景/目的:在许多移植中心,酒精性终末期肝病的肝移植仍存在争议。本研究的目的是评估在博洛尼亚市圣奥索拉综合医院移植中心接受肝移植的酒精性肝病患者的预后。
我们描述了1986年4月至1996年2月期间在本中心接受原位肝移植的18例酒精性终末期肝病患者的预后情况。将获得的数据与114例作为移植对照的病毒相关性肝硬化患者的数据进行比较。要求患者绝对戒酒至少六个月。
关于精算生存率和移植后非致命性并发症,在比较非酒精性受者和酒精性受者时未发现显著差异,除了酒精性组在随访超过四个月时巨细胞病毒感染发生率较高。酒精复发率为27.2%,但只有一名患者恢复到有害饮酒状态。在至少随访六个月的受试者中,73%从事有报酬的工作。酒精复发并未影响就业状况。
这些数据表明,为选定的终末期酒精相关性肝硬化患者进行肝移植在生存、并发症和就业状况方面取得了良好的结果,并且当肝功能严重恶化时,很难坚持在移植前必须证明绝对长期戒酒的严格要求。